Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer.

NPJ Precis Oncol · 2026 · PMC12936199 · PMID 41580469

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Of note, we observed a marginally significant OS separation between patients with >75% ctDNA reduction compared to those without (Supplementary Fig. 3D ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.